Urothelial tissue regulation: Unraveling the role of the stroma

Advances in Experimental Medicine and Biology

Volumn 462, Issue , 1999, Pages 19-30

  Southgate, J ^a   Harnden, P ^a   Selby, P J ^a   Thomas, D F M ^a   Trejdosiewicz, L K ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYTOKERATIN; UROPLAKIN;

BIOENGINEERING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CONFERENCE PAPER; HOMEOSTASIS; HUMAN; MODEL; MONOLAYER CULTURE; NONHUMAN; ORGAN CULTURE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; STROMA; TRANSITIONAL CELL CARCINOMA; URINARY TRACT; UROTHELIUM; WOUND HEALING;

EID: 0033281419     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4737-2_2     Document Type: Conference Paper

References (91)

1. Epithelial integrins
2. Ligand binding and affinity modulation of integrins
3. The mammalian urinary bladder: An accommodating organ
4. The morphology of normal human bladder urothelium
5. The function of the Golgi complex in transitional epithelium. Synthesis of the thick cell membrane
6. Cell lineages and differentiation programs in epidermal, urothelial and hepatic tissues and their neoplasms
7. Proliferative activity of urothelial neoplasms: Comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions
8. Proliferative activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors
9. Cell cycle of normal bladder urothelium in developing and adult mice
10. Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs
11. Proliferative state of the urothelium with benign and atypical changes. Correlation with transferrin and epidermal growth factor receptors and blood group antigens
12. The urinary system - Bladder
13. Carcinoma of the urinary bladder: A review of its diverse morphology
14. Tissue changes following deprivation of fat soluble A vitamin
15. Studies in squamous metaplasia in rat bladder. I. Effects of hypovitaminosis A, foreign bodies and methylcholanthrene
16. Hyperplasia and cornification of the transitional epithelium in vitamin A-deficient rat
17. Effect of retinoid deficiency on keratin expression in mouse bladder
18. Alterations in cytokeratin expression precede histological changes in epithelia of vitamin A-deficient rats
19. Glandular epithelial induction by embryonic mesenchyme in adult bladder epithelium of BALB/c mice
20. Epithelial-mesenchymal interactions in prostatic development. II. Biochemical observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder
21. Unusual forms of carcinoma of the urinary bladder
22. Transitional cell carcinoma of the bladder: Diagnosis and prognosis
23. Two molecular pathways to transitional cell carcinoma of the bladder
24. Molecular genetics of bladder cancer
25. A molecular genetic model of human bladder cancer pathogenesis
26. Monoclonal anti-bodies to human urothelial cell lines and hybrids: Production and characterization
27. Tissue culture model of transitional cell carcinoma: Characterization of twenty-two human urothelial cell lines
28. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines
29. Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression
30. Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins
31. Formation of asymmetric unit membrane during urothelial differentiation
32. Uroplakin I: A 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium
33. Uroplakins 1a and 1b. Two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins
34. Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein sub-unit of asymmetric unit membrane
35. Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein
36. Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation
37. Species Cross-reactive membrane-associated urothelial differentiation antigen
38. Urothelium-specific antibody and lectin surface mapping of bladder urothelium
39. Identification of an 85-100 kDa glycoprotein as a cell surface marker for an advanced stage of urothelial differentiation: Association with the inter-plaque ('hinge') area
40. Classification, expression, and possible mechanisms of evolution of mammalian epithelial keratins: A unifying model
41. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications, and limitations
42. Cytokeratin polypeptide patterns of different epithelia of the human male urogenital tract: Immunofluorescence and gel electrophoretic studies
43. Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13
44. Tissue distribution of keratin 7 as monitored by a monoclonal antibody
45. Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract
46. Patterns of expression of keratin 17 in human epithelia: Dependency on cell position
47. Cytokeratin 20 expression by non-invasive transitional cell carcinomas: Potential for distinguishing recurrent from non-recurrent disease
48. Cytokeratin pattern in normal and pathological bladder urothelium: Immunohistochemical investigation using monoclonal antibodies
49. Keratin expression during neoplastic progression of bladder cancer
50. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression
51. Identification of cells from fetal bladder epithelium in human amniotic fluid
52. Unmasking of a novel lineage-specific keratin epitope during urothelial cytodifferentiation
53. Long-term organ culture of normal human bladder
54. Growth kinetics and differentiation in vitro of normal human uroepithelial cells on collagen gel substrates in defined medium
55. Proliferation of normal and malignant human epithelial cells post irradiation
56. Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells
57. Expression of mal is associated with urothelial differentiation in vitro: Identification by differential display reverse-transcriptase polymerase chain reaction
58. Urothelial tissue culture for bladder reconstruction: An experimental study
59. Normal human urothelial cells in vitro: Proliferation and induction of stratification
60. Expression and in vitro regulation of integrins by normal human urothelial cells
61. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture
62. Changes in keratinocyte adhesion during terminal differentiation: Reduction in fibronectin binding precedes alpha 5 beta 1 integrin loss from the cell surface
63. Reconstitution of human urothelium from monolayer cultures
64. Stromal and vascular invasion in an human in vitro bladder cancer model
65. Growth and characterization of normal human urothelium in vitro
66. Comparison of antigen expression on normal urothelial cells in tissue section and tissue culture
67. Culture and characterisation of human urothelium in vivo and in vitro
68. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro
69. Effect of physical forces on bladder smooth muscle and urothelium
70. Epithelial-stromal interactions in the adult bladder: Urothelial growth, differentiation, and maturation on culture facsimiles of bladder stroma
71. Reconstruction of the urinary bladder mucosa in three-dimensional collagen gel culture: Fibroblast-extracellular matrix interactions on the differentiation of transitional epithelial cells
72. Assessing the differentiation state of cultured bovine urothelial cells: Elevated synthesis of stratification-related K5 and K6 keratins and persistent expression of uroplakin 1
73. Squamous carcinoma of urinary bladder
74. Prediction of response to radiotherapy in invasive bladder cancer
75. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
76. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
77. Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines
78. The effects of dietary fatty acids on the proliferation of normal human urothelial cells in vitro
79. Expression functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells
80. The epidermal growth factor receptor is involved in autocrine growth of human bladder carcinoma cell lines
81. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor
82. Growth factors in bladder wound healing
83. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder
84. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines
85. Wound repair: Overview and general considerations
86. Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma
87. Mechanism of human keratinocyte migration on fibronectin: Unique roles of RGD site and integrins
88. Cytokeratin 20 as an objective marker of urothelial dysplasia
89. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas
90. A novel gene delivery system using urothelial tissue engineered neo-organs